Vigilance is das EU-MDR-System zur Meldung und Untersuchung schwerwiegender Vorkommnisse und Feldkorrekturen (FSCA) bei Medizinprodukten.
Complete Guide to Vigilance
Vigilance is the post-market surveillance system mandated by the EU Medical Device Regulation (MDR 2017/745) for monitoring, reporting, and investigating serious incidents and safety issues involving medical devices. It ensures prompt identification and mitigation of device-related risks to protect patient and user safety.
What constitutes a Serious Incident?
A serious incident is any malfunction or deterioration of a device, or any inadequacy in labeling or instructions that:
- Led to death or serious deterioration in health
- Might lead to death or serious deterioration in health
- Led to or might lead to temporary or permanent injury
Vigilance Reporting Requirements:
Manufacturer Obligations:
- Report serious incidents to competent authorities
- Report Field Safety Corrective Actions (FSCA)
- Investigate incidents thoroughly
- Take corrective actions when needed
- Maintain vigilance database and records
Reporting Timelines:
- Death or imminent risk to life - Immediately (within 2 calendar days)
- Serious deterioration in health - Within 10 calendar days
- Other serious incidents - Within 15 calendar days
- Trend reporting - As soon as detected
Field Safety Corrective Actions (FSCA):
FSCAs are actions taken to reduce risk of death or serious deterioration in health:
- Recall - Return of device to manufacturer
- Modification - Changes to device or software
- Advice - Information to users about device use
- Reports must be submitted before or immediately after implementation
Field Safety Notice (FSN):
Communication to users and customers about:
- Nature of the safety issue
- Devices affected (models, serial numbers)
- Actions users must take
- Timeline for completion
- Contact information for questions
EUDAMED Integration:
All vigilance reports must be submitted through EUDAMED (European Database on Medical Devices):
- Electronic vigilance reporting module
- Centralized database for all EU countries
- Improved transparency and data sharing
- Public access to certain vigilance data
Competent Authority Actions:
National competent authorities may:
- Request additional information
- Conduct inspections
- Require additional corrective actions
- Issue safety communications
- Suspend or withdraw certifications
Key Differences from Other Regions:
- USA (FDA) - Medical Device Reporting (MDR)
- Canada - Mandatory Problem Reporting
- Australia (TGA) - Incident reporting scheme
- Japan (PMDA) - Adverse event reporting
Vigilance Documentation Requirements:
- Incident investigation reports
- Root cause analysis
- Risk assessment updates
- CAPA (Corrective and Preventive Actions)
- Trend analysis reports
- Communication records with authorities
Penalties for Non-Compliance:
- Fines up to €1 million or 7% of annual turnover
- Device recalls or market withdrawal
- Certificate suspension or revocation
- Criminal liability in severe cases
Effective vigilance ensures continuous device safety monitoring and rapid response to emerging risks throughout the product lifecycle.
Related Terms
More Clinical & Post-Market
View allJedes unerwünschte Ereignis im Zusammenhang mit der Verwendung eines Medizinprodukts, einschließlich Patientenschäden, Verletzungen, Fehlfunktionen oder Beinahe-Vorfällen, die den Aufsichtsbehörden gemeldet werden müssen.
Eine systematische Bewertung, die die klinischen Vorteile eines Medizinprodukts mit seinen Risiken vergleicht, um die Akzeptanz für den vorgesehenen Verwendungszweck zu bestimmen.
Ein umfassendes Dokument, das gemäß EU-MDR erforderlich ist und klinische Daten bewertet und dokumentiert, um die Sicherheit und Leistung eines Medizinprodukts nachzuweisen.
Eine systematische Studie an menschlichen Probanden zur Bewertung der Sicherheit und Leistung eines Medizinprodukts, die gemäß EU-Vorschriften für bestimmte Produkte vor der CE-Kennzeichnung erforderlich ist.
Need Help with EU Registration?
Pure Global provides regulatory consulting and AI-powered tools to help medical device companies navigate EU market access.

